Dimitris Veroutis
Overview
Explore the profile of Dimitris Veroutis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magkouta S, Veroutis D, Papaspyropoulos A, Georgiou M, Lougiakis N, Pippa N, et al.
Nat Aging
. 2025 Jan;
PMID: 39890937
No abstract available.
2.
Magkouta S, Veroutis D, Papaspyropoulos A, Georgiou M, Lougiakis N, Pippa N, et al.
Nat Aging
. 2024 Dec;
5(1):162-175.
PMID: 39730824
The emerging field of senolytics is centered on eliminating senescent cells to block their contribution to the progression of age-related diseases, including cancer, and to facilitate healthy aging. Enhancing the...
3.
Tatanis V, Veroutis D, Pantelis P, Theocharous G, Sarlanis H, Georgiou A, et al.
Medicina (Kaunas)
. 2024 Jul;
60(7).
PMID: 39064537
The presence and contribution of senescent cells in premalignant lesions is well documented, but not in germ cell neoplasia in situ. The purpose of this study is to identify the...
4.
Pantelis P, Theocharous G, Veroutis D, Vagena I, Polyzou A, Thanos D, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473720
The currently available anti-cancer therapies, such as gamma-radiation and chemotherapeutic agents, induce cell death and cellular senescence not only in cancer cells but also in the adjacent normal tissue. New...
5.
Magkouta S, Veroutis D, Pousias A, Papaspyropoulos A, Giannetti K, Pippa N, et al.
STAR Protoc
. 2024 Mar;
5(1):102929.
PMID: 38460134
Identification and isolation of senescent cells is challenging, rendering their detailed analysis an unmet need. We describe a precise one-step protocol to fluorescently label senescent cells, for flow cytometry and...
6.
Tatanis V, Veroutis D, Pantelis P, Theocharous G, Sarlanis H, Georgiou A, et al.
Arch Ital Urol Androl
. 2024 Mar;
96(1):12246.
PMID: 38441175
Purpose: The aim of this experimental study is to investigate the correlation between the presence of senescent cells and the tumor size, the lymphovascular invasion (LVI), the invasion of rete...
7.
Veroutis D, Argyropoulou O, Goules A, Kambas K, Palamidas D, Evangelou K, et al.
Ann Rheum Dis
. 2023 Dec;
83(3):342-350.
PMID: 38050005
Objectives: Age is the strongest risk factor of giant cell arteritis (GCA), implying a possible pathogenetic role of cellular senescence. To address this question, we applied an established senescence specific...
8.
Magkouta S, Veroutis D, Pousias A, Papaspyropoulos A, Pippa N, Lougiakis N, et al.
Mol Cell
. 2023 Oct;
83(19):3558-3573.e7.
PMID: 37802028
Cellular senescence is a stress-response mechanism implicated in various physiological processes, diseases, and aging. Current detection approaches have partially addressed the issue of senescent cell identification in clinical specimens. Effective...
9.
Vlachogiannis N, Evangelou K, Ntari L, Nikolaou C, Denis M, Karagianni N, et al.
Mech Ageing Dev
. 2023 Aug;
214:111856.
PMID: 37558168
We had shown that administration of the senolytic Dasatinib abolishes arthritis in the human TNF transgenic mouse model of chronic destructive arthritis when given in combination with a sub-therapeutic dose...
10.
Mourkioti I, Polyzou A, Veroutis D, Theocharous G, Lagopati N, Gentile E, et al.
J Exp Clin Cancer Res
. 2023 Jul;
42(1):187.
PMID: 37507762
Background: Prostate cancer is a major cause of cancer morbidity and mortality in men worldwide. Androgen deprivation therapy (ADT) has proven effective in early-stage androgen-sensitive disease, but prostate cancer gradually...